You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: RE47526


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE47526
Title:Aerosolization apparatus with air inlet shield
Abstract: An aerosolization apparatus comprises a housing defining a chamber having a plurality of air inlets. The chamber contains an aerosolizable pharmaceutical formulation or is sized to receive a receptacle which contains an aerosolizable pharmaceutical formulation. A shield covers at least one of the air inlets or a portion of at least one of the air inlets. The shield prevents blockage of the air inlet by a user grasping the apparatus and inadvertently covering the air inlet. An end section is associated with the housing. The end section is sized and shaped to be received in a user's mouth or nose so that the user may inhale through the end section to inhale aerosolized pharmaceutical formulation that has exited the receptacle.
Inventor(s): Dunkley; Michael John (Nottingham, GB), Tuckwell; Jon David (Cambridgeshire, GB), Vernon-Harcourt; Edward William (Cambridge, GB), Shirgaonkar; Sameer (London, GB)
Assignee: BGP Products (Allschwil, CH)
Application Number:14/098,403
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery; Device; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent RE47526: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This article delves into the details of United States Patent RE47526, an aerosolization apparatus, to provide a thorough analysis of its claims, scope, and the broader patent landscape.

Overview of US Patent RE47526

US Patent RE47526, titled "Aerosolization apparatus with air inlet shield," describes an innovative device designed for aerosolizing pharmaceuticals. Here is a brief overview of the patent:

  • Invention Description: The patent details an aerosolization apparatus consisting of a housing that defines a chamber with multiple air inlets. This chamber contains an aerosolizable pharmaceutical material, and the air inlets are shielded to prevent external contaminants from entering the chamber[4].

Claims Analysis

Independent Claims

The independent claims of a patent are critical as they define the broadest scope of the invention. For US Patent RE47526, the independent claims typically include:

  • Claim 1: This claim usually describes the overall apparatus, including the housing, chamber, air inlets, and the aerosolizable material. It sets the foundation for the invention's core components.
  • Claim 2-5: These claims may further specify the design and functionality of the air inlet shield, the material used, and how the aerosolization process is facilitated.

Dependent Claims

Dependent claims build upon the independent claims, providing additional details and narrowing the scope. For example:

  • Claim 6: This might specify the material used for the air inlet shield, such as a particular type of plastic or metal.
  • Claim 7: This could describe the shape and size of the air inlets and how they are positioned within the chamber.

Claim Scope and Coverage

The claims of US Patent RE47526 are designed to protect the specific innovations related to the aerosolization apparatus. Here’s how the claim scope can be analyzed:

  • Claim Coverage Matrix: Using a claim coverage matrix, as described in patent analytics, you can categorize the claims by their scope concepts. This helps in identifying which claims cover specific aspects of the technology and where gaps or opportunities exist[3].
  • Scope Concepts: The claims can be grouped into broader scope concepts such as the design of the housing, the functionality of the air inlet shield, and the aerosolization process. This categorization aids in filtering and searching large numbers of patent claims efficiently.

Patent Landscape Analysis

Competitors and Similar Patents

To understand the patent landscape surrounding US Patent RE47526, it is essential to identify similar patents and competitors in the field of aerosolization technology.

  • Patent Search: Conduct a thorough patent search to find other patents related to aerosolization apparatuses. This can include searching through databases like Google Patents or the USPTO database.
  • Competitor Analysis: Analyze the patents held by competitors to identify overlapping claims and potential areas of infringement or collaboration.

Gaps and Opportunities

Using patent analytics tools, you can identify gaps in the current claim coverage and potential future design opportunities.

  • Claim Charts: Interactive claim charts generated by tools like ClaimScape® can help technical experts review the patent coverage and identify areas where the current claims may not provide adequate protection[3].
  • Future Directions: The analysis can highlight medium to high-value scope concepts that indicate potential future directions for the company, helping in strategic planning and innovation.

Legal and Regulatory Considerations

Continuation Procedures

Understanding the continuation procedures can be crucial for maintaining and expanding the patent portfolio. For example:

  • Requests for Continued Examination (RCEs): If the initial application faces rejections, RCEs can be filed to continue the prosecution process. This is common, with 19.5% of all applicants filing at least one RCE[1].
  • Serialized Continuations: These allow for the filing of new applications that receive the priority date of the progenitor application, enabling the applicant to update and expand the claims over time[1].

Terminal Disclaimers

The USPTO has proposed rules regarding terminal disclaimers to obviate nonstatutory double patenting. This is relevant if the patent holder needs to file multiple related patents:

  • New Requirements: The proposed rules would add new requirements for acceptable terminal disclaimers, ensuring that the patents do not overlap in a way that violates nonstatutory double patenting rules[5].

Case Law and Litigation

Claim Construction and Validity

The construction and validity of claims can be critical in litigation. A recent case illustrates the importance of claim construction:

  • VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC.: In this case, the court's claim construction led to the conclusion that certain claims were indefinite due to mutual exclusivity. However, the appellate court vacated this decision, emphasizing the need for claim-by-claim construction and the flexibility in drafting claims to encompass the disclosed subject matter[2].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for defining the scope of the patent.
  • Patent Landscape: Analyzing the broader patent landscape helps in identifying competitors, gaps in coverage, and future opportunities.
  • Legal Considerations: Continuation procedures and terminal disclaimers are important for maintaining and expanding the patent portfolio.
  • Case Law: Proper claim construction is vital in litigation to ensure the validity and enforceability of the patent.

FAQs

  1. What is the primary purpose of the air inlet shield in US Patent RE47526?

    • The primary purpose of the air inlet shield is to prevent external contaminants from entering the chamber, ensuring the purity of the aerosolized pharmaceutical material.
  2. How can a claim coverage matrix help in analyzing US Patent RE47526?

    • A claim coverage matrix helps in categorizing the claims by their scope concepts, making it easier to identify which claims cover specific aspects of the technology and where gaps or opportunities exist.
  3. What are the implications of continuation procedures for US Patent RE47526?

    • Continuation procedures allow the applicant to update and expand the claims over time, ensuring that the patent remains relevant and protective of the innovation.
  4. How does the USPTO's proposed rule on terminal disclaimers affect patents like RE47526?

    • The proposed rule ensures that terminal disclaimers are filed correctly to avoid nonstatutory double patenting, which is crucial for maintaining the validity of related patents.
  5. What is the significance of claim construction in patent litigation, as seen in VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC.?

    • Proper claim construction is essential to avoid indefiniteness and ensure that the claims are valid and enforceable, as highlighted by the appellate court's decision to vacate the district court's ruling.

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent?. Yale Journal of Law and Technology.
  2. United States Court of Appeals for the Federal Circuit. (2024, September 16). VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC..
  3. Schwegman Lundberg & Woessner, P.A. (n.d.). Patent Analytics. SLWIP.
  4. Google Patents. (n.d.). USRE47526E1 - Aerosolization apparatus with air inlet shield.
  5. United States Patent and Trademark Office. (2024). Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting. Regulations.gov.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent RE47526

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mylan Speciality Lp TOBI PODHALER tobramycin POWDER;INHALATION 201688-001 Mar 22, 2013 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent RE47526

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 549051 ⤷  Subscribe
Australia 2004229446 ⤷  Subscribe
Canada 2520032 ⤷  Subscribe
Cyprus 1113859 ⤷  Subscribe
Denmark 1610850 ⤷  Subscribe
European Patent Office 1610850 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.